The Un-Aggregated Economy: Supply Chain Realities in Hong Kong's Long Tail AssetsGlobal Report·Jul 25 at 04:13 AM02459-1.79%01111+3.35%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase cancellationPUBT·Jul 16 at 05:27 AM03378+3.63%
Hanx Biopharma files HKEX next-day disclosure return on share repurchasePUBT·Jul 15 at 06:33 AM03378+3.63%
Hanx Biopharmaceuticals files HKEX next-day disclosure after share repurchasePUBT·Jul 14 at 06:25 AM03378+3.63%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchasePUBT·Jul 13 at 05:48 AM03378+3.63%
Can AI collaborations power China’s next wave of blockbuster drug deals?SCMP·Jul 13 at 05:33 AM01093+0.35%03378+3.63%
Hanx Biopharma files HKEX next-day return disclosing share buyback at HKD 28.96 eachPUBT·Jul 10 at 06:19 AM03378+3.63%
Hanx Biopharmaceuticals files HKEX next-day return disclosing share buyback at HKD 28.63 eachPUBT·Jul 9 at 04:58 AM03378+3.63%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 28.91 avg pricePUBT·Jul 7 at 06:28 AM03378+3.63%
Hanx Biopharmaceuticals posts announcement on AI-driven drug discovery collaborationPUBT·Jul 7 at 05:54 AM03378+3.63%
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 28.68 avgPUBT·Jul 3 at 06:28 AM03378+3.63%
Hanx Biopharmaceuticals partners with TwinEdge Bioscience on AI-driven HX009 developmentPUBT·Jul 2 at 09:54 AM03378+3.63%
Hanx Biopharma files HKEX next-day disclosure return on share repurchase at HKD 28.68-$27.96PUBT·Jul 2 at 06:21 AM03378+3.63%
